FDA Grants De Novo Status for Wearable System to Treat RLS

The FDA granted Noctrix Health its De Novo request for the NTX100 Tonic Motor Activation System for certain restless legs syndrome patients.

Related Keywords

Ohio ,United States ,Asim Roy ,Shri Raghunathan ,Mark Buchfuhrer ,Noctrix Health ,Stanford University School Of Medicine ,Drug Administration ,Ohio Sleep Medicine Institute ,Motor Activation System ,Breakthrough Device Designation ,Stanford University School ,